Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Galili

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|August 1, 1984
Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B-type CLL and CLL in 'prolymphocytoid' transformationA Polliack, R Leizerowitz, A Berrebi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Prothymocytes in postirradiation regenerating rat thymuses: a model for studying early stages in T cell differentiationR C Castellanos, R Leizerovitz, N Kaiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemiaY Ito, R Wasserman, N Galili, et al.
Nature Genetics|February 1, 1993
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaF G Barr, N Galili, J Holick, et al.
Annals of Hematology|April 1, 2005
Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromesA Candoni, A Raza, F Silvestri, et al.
Cancer Research|June 13, 2000
Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasisD Aviezer, S Cotton, M David, et al.
Leukemia|August 1, 1990
Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemiaS Kohler, N Galili, J L Sklar, et al.
Molecular and Cellular Biology|March 1, 1995
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3W J Fredericks, N Galili, S Mukhopadhyay, et al.
Cell|February 23, 1990
Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factorJ Nourse, J D Mellentin, N Galili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stageR Wasserman, Y Ito, N Galili, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|August 1, 1984
Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B-type CLL and CLL in 'prolymphocytoid' transformationA Polliack, R Leizerowitz, A Berrebi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Prothymocytes in postirradiation regenerating rat thymuses: a model for studying early stages in T cell differentiationR C Castellanos, R Leizerovitz, N Kaiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemiaY Ito, R Wasserman, N Galili, et al.
Nature Genetics|February 1, 1993
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaF G Barr, N Galili, J Holick, et al.
Annals of Hematology|April 1, 2005
Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromesA Candoni, A Raza, F Silvestri, et al.
Cancer Research|June 13, 2000
Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasisD Aviezer, S Cotton, M David, et al.
Leukemia|August 1, 1990
Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemiaS Kohler, N Galili, J L Sklar, et al.
Molecular and Cellular Biology|March 1, 1995
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3W J Fredericks, N Galili, S Mukhopadhyay, et al.
Cell|February 23, 1990
Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factorJ Nourse, J D Mellentin, N Galili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stageR Wasserman, Y Ito, N Galili, et al.
Pageof 6